IDP Pharma

IDP Pharma is a clinical-stage biotechnology company developing the first direct inhibitors and degraders of intrinsically disordered proteins (IDPs), a novel class of disease drivers previously considered undruggable. Thanks to its proprietary Intrametics™ platform, the company has successfully developed a first-in-class pipeline of drugs targeting IDPs and has been at the forefront since its inception.